For the Quarter Ending March 2026
Losartan Potassium Prices in APAC
- In China, the Losartan Potassium Price Index fell by 2.70% quarter-over-quarter, reflecting weaker export demand.
- The average Losartan Potassium price for the quarter was approximately USD 35400.00/MT, indicating subdued buying.
- Losartan Potassium Spot Price firmed in March as export enquiries increased and bonded inventories tightened.
- Losartan Potassium Price Forecast expects modest post-March gains driven by export restocking and plant runs.
- Losartan Potassium Production Cost Trend remained contained as tetrazole and potassium-hydroxide feedstock prices stayed stable.
- Losartan Potassium Demand Outlook strengthened overseas with US and Brazil tender activity supporting contracted shipments.
- Losartan Potassium Price Index showed a March uptick as GMP re-qualification reduced available export-allocated capacity.
- Exporters discounted FOB offers to clear rising inventories, then raised quotes as bonded stocks declined.
Why did the price of Losartan Potassium change in March 2026 in APAC?
- GMP re-qualifications temporarily removed export-qualified lines, tightening supply and supporting firmer FOB offers in March.
- Front-loaded US and Brazilian tendering accelerated purchases, drawing down bonded inventories and strengthening export demand.
- Stable feedstock costs offered limited relief while compliance and shipping considerations kept producer offers elevated.
Losartan Potassium Prices in North America
- In the USA, the Losartan Potassium Price Index declined slightly quarter-over-quarter, reflecting earlier weak import demand and sufficient inventory coverage.
- Losartan Potassium Spot Price firmed in March as tightening export availability from China and increased tender-driven demand reduced immediate supply.
- Losartan Potassium Production Cost Trend remained stable, as upstream feedstock costs such as tetrazole and potassium hydroxide showed limited fluctuation.
- The Losartan Potassium Demand Outlook improved, supported by public health procurement programs and renewed buying interest from distributors.
- The Losartan Potassium Price Forecast modest near-term gains, driven by restocking cycles and constrained export supply.
- Inventory levels across US distribution channels tightened slightly as March procurement accelerated and replenishment lagged.
- Import dependence on Chinese suppliers exposed the market to supply disruptions caused by GMP-related capacity constraints.
- Suppliers adjusted pricing upward in March, following earlier discounts, as export demand strengthened and inventories declined.
Why did the price of Losartan Potassium change in March 2026 in North America?
- GMP-related production constraints in China reduced export availability, tightening the US supply.
- Increased procurement from healthcare tenders accelerated inventory drawdowns.
- Stable feedstock costs offered limited cost relief, allowing suppliers to raise prices amid stronger demand.
Losartan Potassium Prices in Europe
- In Germany, the Losartan Potassium Price Index showed a slight decline quarter-over-quarter, reflecting subdued early-quarter demand and adequate inventories.
- Losartan Potassium Spot Price strengthened in March as reduced export supply from China and improved demand tightened prompt availability.
- Losartan Potassium Production Cost Trend remained stable, supported by unchanged feedstock pricing and controlled upstream costs.
- The Losartan Potassium Demand Outlook improved, driven by steady pharmaceutical demand and tender-based procurement across Europe.
- The Losartan Potassium Price Forecast suggests mild upward movement, supported by restocking activity and constrained supply conditions.
- Inventory levels across European hubs declined slightly due to increased March purchasing and delayed replenishment.
- Import reliance on Asia made the market sensitive to GMP compliance disruptions affecting export-qualified capacity.
- Suppliers maintained firmer pricing in March, reflecting reduced availability and improving demand conditions.
Why did the price of Losartan Potassium change in March 2026 in Europe?
- GMP re-qualification in China reduced export-ready supply, tightening availability in Europe.
- Increased tender activity and restocking demand accelerated inventory drawdowns.
- Stable input costs allowed suppliers to pass through higher prices amid stronger demand and constrained supply.
For the Quarter Ending December 2025
APAC
- In China, the Losartan Potassium Price Index rose by 0.53% quarter-over-quarter, reflecting policy and supply adjustments recently.
- The average Losartan Potassium price for the quarter was approximately USD 36383.33/MT as reported by FOB Zhejiang.
- Balanced export bookings supported the Losartan Potassium Spot Price, while domestic procurement remained cautious and inventories were adequate.
- Short-term Losartan Potassium Price Forecast indicates mild corrections into year-end as traders prioritize inventory reduction measures.
- Stable raw material flows preserved the Losartan Potassium Production Cost Trend, limiting margin erosion despite export premiums.
- Dampened procurement under VBP influenced the Losartan Potassium Demand Outlook, keeping offtake steady but non-expansive during December.
- Monthly Price Index readings showed limited volatility as logistics remained smooth and coastal inventories stayed within targets.
- Producers maintained volumes to meet contracted shipments, preventing tightness while preserving export competitiveness and a steady realization period.
Why did the price of Losartan Potassium change in December 2025 in APAC?
- Exporters offered discounts to secure cargoes ahead of Lunar New Year logistics slowdown and softer spot demand.
- Feedstock stability and steady coal-based power costs prevented upward pressure despite reduced incremental export procurement during December.
- Mutual effects of VBP domestic price ceilings and prior forward coverages by buyers softened fresh buying interest.
Europe
- In Europe, the Losartan Potassium Price Index edged slightly higher quarter-over-quarter, influenced by import logistics and inventory adjustments.
- Losartan Potassium market conditions remained import-led, with Asian shipments supplying pharmaceutical distributors and hospital programs.
- Losartan Potassium Spot Price stayed stable as adequate port arrivals met routine procurement, keeping immediate pricing pressure limited.
- Short-term Losartan Potassium Price Forecast indicates mild correction into early 2026, as buyers manage inventories and plan year-end procurement.
- Losartan Potassium Production Cost Trend for importers remained steady, supported by stable feedstock and predictable freight costs.
- Dampened domestic tendering and procurement cycles kept the Losartan Potassium Demand Outlook balanced, with no significant expansion in offtake during December.
- Price Index volatility was limited, aided by smooth European port operations and consistent distributor stock levels.
- Importers maintained volumes to cover institutional and hospital requirements, avoiding tightness while preserving term contract competitiveness.
Why did the price of Losartan Potassium change in December 2025 in Europe?
- Sufficient Asian imports met routine demand, reducing urgency and moderating spot-price pressure.
- Stable feedstock and freight costs limited input-driven upward pressure on landed prices.
- Institutional buyers deferred incremental purchases near year-end, softening fresh demand.
North America
- In North America, the Losartan Potassium Price Index showed modest quarter-over-quarter firmness, influenced by stable import availability and cautious institutional buying.
- Losartan Potassium market conditions remained import-led, with India and China supplying most shipments for hospitals, distributors, and government programs.
- Losartan Potassium Spot Price stayed near monthly averages as distributors maintained adequate inventory, reducing urgency-driven pricing swings.
- Short-term Losartan Potassium Price Forecast signals mild corrections into early 2026, as buyers pace orders against anticipated restocking cycles.
- Losartan Potassium Production Cost Trend for importers remained broadly stable, with consistent feedstock pricing and predictable logistics maintaining landed-cost equilibrium.
- Demand Outlook stayed steady, with procurement from hospitals, pharmacies, and government health programs balancing seasonal consumption variations.
- Price Index readings reflected narrow movements, supported by stable port operations, timely customs clearance, and sufficient cargo arrivals.
- Importers managed volumes to meet contractual requirements, preventing tightness while allowing moderate spot flexibility.
Why did the price of Losartan Potassium change in December 2025 in North America?
- Stable export offers from India and China kept landed costs steady, limiting upward price pressure.
- Reduced year-end procurement softened immediate demand, moderating spot price activity.
- Predictable feedstock and shipping costs prevented cost-push, enabling importers to maintain competitive offers.
For the Quarter Ending September 2025
APAC
- In China, the Losartan Potassium Price Index fell by 2.66% quarter-over-quarter, due to high inventories.
- The average Losartan Potassium price for the quarter was approximately USD 50100.00/MT, FOB Zhejiang reported.
- Losartan Potassium Spot Price remained pressured while the Price Index reflected oversupply and weaker-than-expected procurement.
- Losartan Potassium Price Forecast indicates modest recovery as seasonal restocking and scheduled maintenance tighten availability.
- Losartan Potassium Production Cost Trend shows easing feedstock expenses, supporting pressure on producer margins recently.
- Losartan Potassium Demand Outlook remains muted as downstream pharmaceutical procurement stays cautious amid elevated stocks.
- Price Index shifts reflected accelerated stock clearance, weak export orders and sustained domestic production availability.
- Producers resumed operations after maintenance, but export demand softness and currency adjustments constrained price recovery.
Why did the price of Losartan Potassium change in September 2025 in APAC?
- Increased local availability after plant restarts elevated inventories, prompting sellers to lower export pricing aggressively.
- Subdued overseas procurement and tariff truce extension reduced forward buying, weakening international demand for shipments.
- Easing production input costs offset partly by rising freight and currency shifts, resulting in mixed net price pressure.
Europe
- In the Netherlands, the Losartan Potassium Price Index declined quarter-over-quarter, reflecting subdued import activity and stable inventory positions across major distributors.
- Losartan Potassium Spot Price remained under mild pressure as ample supply from Asian exporters and cautious European procurement limited transactional momentum.
- Losartan Potassium Price Forecast indicates a potential mild recovery in late months, supported by seasonal restocking and gradual stabilization in pharmaceutical manufacturing schedules.
- Losartan Potassium Production Cost Trend for importers eased, driven by lower API prices and favorable freight adjustments, marginally improving landed cost competitiveness.
- Losartan Potassium Demand Outlook stayed moderate, as consistent domestic formulations demand was offset by cautious purchasing behavior amid sufficient stock levels.
- The regional Price Index movement reflected balanced inventory management, steady logistics, and the availability of competitively priced Asian offers.
- Importers maintained disciplined buying patterns, focusing on minimizing overstocking while monitoring global API price movements.
- Stable shipping conditions and predictable supply from Asia helped maintain low volatility, although subdued demand limited upward price traction.
Why did the price of Losartan Potassium change in September 2025 in Europe?
- Competitive Asian export quotations reduced landed costs, putting downward pressure on European Losartan Potassium prices.
- Adequate domestic inventories and conservative procurement strategies among European buyers limited restocking activity and muted price increases.
- Softer input and freight costs further eased overall import expenses, supporting a mild decline in regional market prices.
North America
- In the USA, the Losartan Potassium Price Index declined quarter-over-quarter, influenced by weaker import quotations from Asian suppliers and adequate distributor inventories.
- Losartan Potassium Spot Price softened as abundant supply and cautious pharmaceutical procurement limited upward price movement.
- Losartan Potassium Price Forecast indicates mild recovery potential in Q4, supported by seasonal restocking and gradual downstream demand improvement.
- Losartan Potassium Production Cost Trend for importers eased as lower API prices and moderate freight adjustments reduced overall landed costs.
- Losartan Potassium Demand Outlook remained moderate, with conservative purchasing amid sufficient stocks across pharmaceutical distributors.
- Price Index movements reflected competitive Asian export offers, stable logistics, and controlled restocking activity from downstream users.
- Importers maintained disciplined buying patterns, minimizing overstocking while monitoring market and currency trends.
- Smooth shipping operations and steady Asian supply helped maintain low market volatility despite limited immediate demand increases.
Why did the price of Losartan Potassium change in September 2025 in North America?
- Softer Asian export offers and steady supply reduced landed import costs, contributing to a weaker Price Index.
- Sufficient inventories and cautious procurement from pharmaceutical manufacturers limited transactional activity and price recovery.
- Moderate freight costs and currency adjustments further eased import expenses, restraining any immediate upward pressure on pricing.
For the Quarter Ending June 2025
North America
- Losartan Potassium Price Index in North America moved higher in July 2025 after a period of relative stability in June, driven by stronger restocking trends and tightened regional availability.
- Spot Price in the U.S. market saw upward movement as buyers resumed active procurement following lean offtake in the previous month and firming global supplier offers.
- In April and May 2025, prices moved higher due to reduced import volumes from Asia, coupled with delayed shipments and limited domestic reserves, supporting stronger pricing momentum.
- In June 2025, the Price Index remained mostly stable as excess inventories, weak summer demand from hospitals, and competitive offers from Asian suppliers exerted downward pressure.
- Production Cost Trend stayed moderate in July as upstream input prices stabilized, though increased freight costs and firm Asian supplier quotations contributed to landed cost pressure.
- Demand Outlook improved in July, led by renewed interest from downstream pharmaceutical formulators and distributors preparing for seasonal Q3 consumption cycles.
- Inventory levels began to normalize, with distributors covering short-term gaps as export order fulfillment from Asia became more selective and price-sensitive.
- Export competitiveness of Asian suppliers decreased slightly in July, giving U.S. buyers less room to negotiate and pushing them to accept higher offer levels to secure supply.
- Price Forecast for Q3 2025 is bullish, as tighter global supply, improving regional demand, and rising restocking interest are expected to sustain upward price pressure through the quarter.
Why did the price change in July 2025?
- Prices increased due to a combination of rising procurement from downstream drug manufacturers, limited spot supply availability, and reduced pricing flexibility from key Asian exporters.
Europe
- Losartan Potassium Price Index in Europe showed an upward trend in July 2025, supported by increased procurement activity and tighter regional availability.
- Spot Price for Losartan Potassium in Germany rose as downstream pharmaceutical buyers intensified restocking efforts ahead of the Q3 demand cycle.
- In June 2025, the Losartan Potassium Price Index had declined amid high inventory levels and sluggish institutional demand across Western Europe.
- Production Cost Trend for Losartan Potassium remained steady, though minor increases in shipping costs and regulatory compliance slightly impacted landed costs.
- The Demand Outlook improved in July 2025, driven by preparations for seasonal surges in antihypertensive drug consumption and renewed purchases from public and private healthcare channels.
- Supply constraints from Asia, particularly China and India, reduced the availability of bulk Losartan Potassium shipments, contributing to firm regional pricing.
- Wholesalers in Germany reported leaner safety stocks and adopted short-term contracts at higher rates, supporting stronger market sentiment.
- The market also witnessed more frequent spot inquiries as formulation plants sought to secure forward coverage amid rising freight and regulatory headwinds.
- Price Forecast for Q3 2025 suggests continued upward momentum, underpinned by strong demand expectations and export limitations from major API-producing nations.
Why did the price change in July 2025?
- Losartan Potassium prices increased due to restocking by pharmaceutical buyers in Germany, limited exports from Asian suppliers, and improving demand prospects for Q3.
APAC
- Price Index for Losartan Potassium in APAC (China) witnessed an upward adjustment in July 2025, reversing the softening trend from June and driven by restocking activity and rising trade interest.
- Spot Price for Losartan Potassium (USP) FOB Zhejiang (China) rose in July 2025 compared to June levels of USD 52,900/MT, reflecting stronger procurement and recovering global offtake.
- In April 2025, prices rose by 0.62% due to front-loaded exports ahead of US tariff changes, reduced production activity, and limited inventory, which kept market supply tight and prices firm.
- In May 2025, prices jumped by 9.28% as supply remained constrained amid rising demand, early-month production shutdowns, and renewed US buying interest following eased trade tariffs.
- In June 2025, prices corrected downward by 0.19% due to elevated inventory levels, weak overseas orders, and falling input costs, which created pressure on suppliers to lower prices.
- Production Cost Trend in July 2025 shifted upward slightly, influenced by firmer raw material prices and moderate increases in manufacturing utility expenses compared to June.
- Demand Outlook improved, supported by renewed buying activity from Southeast Asian countries and moderate recovery in overseas inquiries, particularly from the US and EU pharmaceutical sectors.
- Export competitiveness also strengthened slightly, as freight volatility stabilized and buyer sentiment improved due to easing cost pressures and anticipation of Q3 procurement cycles.
- Inventory dynamics saw partial clearing at the supplier level due to active order placement early in the month, although stock levels remained above seasonal averages by end-July.
- Price Forecast for August 2025 indicates a potential further increase, as downstream pharmaceutical restocking in APAC and global trade stabilization are expected to support firmer prices.
Why did the price change in July 2025?
- Prices increased due to renewed export activity, improved international buying sentiment, and supplier efforts to push up offers amid stabilizing inventory and raw material cost uptick.
